PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
From:
Neuropharmacology. Author manuscript; available in PMC 2011 January 1.
Published in final edited form as:
Neuropharmacology. 2010 January; 58(1): 156–165.
Published online 2009 July 14. doi: 10.1016/j.neuropharm.2009.07.009

Figure 8

An external file that holds a picture, illustration, etc.
Object name is nihms132183f8.jpg
Ambulatory velocity in chamber # 2

Untreated nestin/hRAMP1 move slower than control mice (*P < 0.01) except in the second interval in the light. There were not differences between CGRP-treated nestin/hRAMP1 and control mice. Nestin/hRAMP1 mice treated with CGRP moved faster compared with vehicle, but this only reached significance in the dark in the first (#P = 0.007) and second (#P = 0.049) intervals. CGRP-treated control mice moved faster than vehicle-treated mice in the dark in the first (‡P = 0.001) and second (‡P = 0.003) intervals and in the light in the first interval (‡P < 0.001) and second interval (P = 0.07). Control, untreated: n = 13; nestin/hRAMP1, untreated : n = 12; all other groups: n = 8. Mean ± s.e.m.

Images in this article

  • Figure 1
  • Figure 2
  • Figure 3
  • Figure 4
  • Figure 5
  • Figure 6
  • Figure 7
  • Figure 8
Click on the image to see a larger version.